Chi Huang

Apr 1, 2024 | the-hospitalist.org | Chi Huang |Ronda Whitaker

Clinical question: Are there increased adverse outcomes with the utilization of cefepime or piperacillin-tazobactam? Background: Hospitalists frequently prescribe cefepime or piperacillin-tazobactam for antipseudomonal coverage. There have been reports stating that there is an increased incidence of change in mental status in the use of cefepime.

Apr 1, 2024 | the-hospitalist.org | Chi Huang |Ronda Whitaker

Clinical question: What is the time to benefit for patients with heart failure (HF) and prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor? Background: SGLT-2 inhibitors are an effective medication for patients with heart failure and preserved (HFpEF) or reduced ejection fraction (HRrEF). Study design: Comparative effectiveness studySetting: The authors conducted a systematic review of the literature up to the date of September 5, 2022.

Sep 8, 2023 | dovepress.com | Peng Guo |Chi Huang |Qin Yang |Guofeng Zhong

Peng Guo,1,* Chi Huang,2,* Qin Yang,1 Guofeng Zhong,1 Junbo Zhang,1 Mengyu Qiu,1 Rui Zeng,3 Kaijun Gou,3 Chen Zhang,1 Yan Qu1 1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People’s Republic of China; 2Department of Pharmacy, Jiang’an Hospital of Traditional Chinese Medicine, Yibin, 644200, People’s Republic of China; 3Institute of Tibetan Plateau, Southwest Minzu University,...